Role of connexin (gap junction) genes in cell growth control and carcinogenesis

Citation
H. Yamasaki et al., Role of connexin (gap junction) genes in cell growth control and carcinogenesis, CR AC S III, 322(2-3), 1999, pp. 151-159
Citations number
65
Categorie Soggetti
Multidisciplinary,"Experimental Biology
Journal title
COMPTES RENDUS DE L ACADEMIE DES SCIENCES SERIE III-SCIENCES DE LA VIE-LIFE SCIENCES
ISSN journal
07644469 → ACNP
Volume
322
Issue
2-3
Year of publication
1999
Pages
151 - 159
Database
ISI
SICI code
0764-4469(199902/03)322:2-3<151:ROC(JG>2.0.ZU;2-4
Abstract
Gap junctional intercellular communication (GJIC) is considered to play a k ey role in the maintenance of tissue independence and homeostasis in multic ellular organ isms by controlling the growth of GI I C-connected eel Is. Ga p junction channels are composed of connexin molecules and, so far, more th an a dozen different connexin genes have been shown to be expressed in mamm als. Reflecting the importance of GJIC in various physiological functions, deletion of different connexin genes from mice results in various disorders , including cancers, heart malformation or conduction abnormality, cataract , etc. The possible involvement of aberrant GJIC in abnormal cell growth an d carcinogenesis has long been postulated and recent studies in our own and other laboratories have confirmed that expression and function of connexin genes play an important role in cell growth control. Thus, almost all mali gnant cells show altered homologous and/or heterologous GJIC and are often associated with aberrant expression or localization of connexins. Aberrant localization of connexins in some tumour cells is associated with lack of f unction of cell adhesion molecules, suggesting the importance of cell-cell recognition for GJIC. Transfection of connexin genes into tumorigenic cells restores normal cell growth, supporting the idea that connexins form a fam ily of tumour-suppressor genes. Some studies also show that specific connex ins may be necessary to control growth of specific cell types. We have prod uced various dominant-negative mutants of Cx26, Cx32 and Cx43 and showed th at some of them prevent the growth control exerted by the corresponding wil d-type genes. However, we have found that connexins 32, 37 and 43 genes are rarely mutated in tumours. In some of these studies, we noted that connexi n expression per se, rather than GJIC level, is more closely related to gro wth control, suggesting that connexins may have a GJIC-independent function . We have recently created a transgenic mouse strain in which a mutant Cx32 is specifically overexpressed in the liver. Studies with such mice indicat e that Cx32 plays a key role in liver regeneration after partial hepatectom y. A decade ago, we proposed a method to enhance killing of cancer cells by diffusion of therapeutic agents through GJIC. Recently, we and others have shown that GJIC is responsible for the bystander effect seen in HSV-tk/gan ciclovir gene therapy. Thus, connexin genes can exert dual effects in tumou r control: tumour suppression and a bystander effect for cancer therapy. (( C) Academie des sciences / Elsevier, Paris.)